24
Views
21
CrossRef citations to date
0
Altmetric
Original Article

The Arginine-Nitric Oxide Pathway in Thrombotic Microangiopathy

, , , &
Pages 477-479 | Received 20 Apr 1996, Accepted 29 Nov 1996, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anders Pettersson, Thomas Hedner & Ian Milsom. (1998) Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstetricia et Gynecologica Scandinavica 77:8, pages 808-813.
Read now

Articles from other publishers (20)

Chao Xuan, Qing-Wu Tian, Hui Li, Bei-Bei Zhang, Guo-Wei He & Li-Min Lun. (2015) Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: A meta-analysis based on 4713 participants. European Journal of Preventive Cardiology 23:5, pages 502-510.
Crossref
Nele Kirsten Kanzelmeyer, Lars Pape, Kristine Chobanyan-Jürgens, Dimitrios Tsikas, Hans Hartmann, Anne-Jule Fuchs, Bernhard Vaske, Anibh Martin Das, Marion Haubitz, Jens Jordan & Thomas Lücke. (2014) L-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS). Oxidative Medicine and Cellular Longevity 2014, pages 1-9.
Crossref
R. N. Rodionov, I. O. Blokhin, M. M. Galagudza, E. V. Shlyakhto & S. R. Lentz. (2008) The emerging role of asymmetric dimethylarginine in cardiovascular disease. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 14:4, pages 306-314.
Crossref
J. Thachil. (2008) The difficult distinction between haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Clinical Kidney Journal 1:2, pages 132-133.
Crossref
James M. Leiper & Patrick Vallance. (2005) The synthesis and metabolism of asymmetric dimethylarginine (ADMA). European Journal of Clinical Pharmacology 62:S1, pages 33-38.
Crossref
Shelagh Anthony, James Leiper & Patrick Vallance. (2016) Endogenous production of nitric oxide synthase inhibitors. Vascular Medicine 10:1_suppl, pages S3-S9.
Crossref
Shelagh Anthony, James Leiper & Patrick Vallance. (2016) Endogenous production of nitric oxide synthase inhibitors. Vascular Medicine 10:2_suppl, pages S3-S9.
Crossref
Stefania Bergamini, Lorenza Vandelli, Elisa Bellei, Cristina Rota, Paolo Manfredini, Aldo Tomasi, Alberto Albertazzi & Anna Iannone. (2004) Relationship of asymmetric dimethylarginine to haemodialysis hypotension. Nitric Oxide 11:3, pages 273-278.
Crossref
Cam T.L Tran, James M Leiper & Patrick Vallance. (2003) The DDAH/ADMA/NOS pathway. Atherosclerosis Supplements 4:4, pages 33-40.
Crossref
Graciela I. Dran, Gabriela C. Fernández, Carolina J. Rubel, Emilse Bermejo, Sonia Gomez, Roberto Meiss, Martín A. Isturiz & Marina S. Palermo. (2002) Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome. Kidney International 62:4, pages 1338-1348.
Crossref
HITOSHI MASUDA, TOSHIHIKO TSUJII, TETSUO OKUNO, KAZUNORI KIHARA, MORITAKA GOTO & HIROSHI AZUMA. (2002) Localization and Role of Nitric Oxide Synthase and Endogenous Nitric Oxide Synthase Inhibitors in the Rabbit Lower Urinary Tract. The Journal of Urology, pages 2235-2240.
Crossref
HITOSHI MASUDA, TOSHIHIKO TSUJII, TETSUO OKUNO, KAZUNORI KIHARA, MORITAKA GOTO & HIROSHI AZUMA. (2002) Localization and Role of Nitric Oxide Synthase and Endogenous Nitric Oxide Synthase Inhibitors in the Rabbit Lower Urinary Tract. Journal of Urology 167:5, pages 2235-2240.
Crossref
Hitoshi MASUDA & Hiroshi AZUMA. (2002) Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase. Folia Pharmacologica Japonica 119:1, pages 29-35.
Crossref
Jiyun Kim, Hong Wu, Lesleyann Hawthorne, Shahin Rafii & Jeffrey Laurence. (2001) Endothelial Cell Apoptotic Genes Associated with the Pathogenesis of Thrombotic Microangiopathies: An Application of Oligonucleotide Genechip Technology. Microvascular Research 62:2, pages 83-93.
Crossref
Gale McCarty. 2001. Vascular Manifestations of Systemic Autoimmune Diseases. Vascular Manifestations of Systemic Autoimmune Diseases.
Duane T. Lowe. (2000) Nitric Oxide Dysfunction in the Pathophysiology of Preeclampsia. Nitric Oxide 4:4, pages 441-458.
Crossref
Xin J Zhou, Zoltan Laszik, Zhenmin Ni, Xiu Q Wang, Daniel J Brackett, Megan R Lerner, Fred G Silva & Nosratola D Vaziri. (2000) Down-Regulation of Renal Endothelial Nitric Oxide Synthase Expression in Experimental Glomerular Thrombotic Microangiopathy. Laboratory Investigation 80:7, pages 1079-1087.
Crossref
Jenifer L. Jaeger & David W. K. Acheson. (2000) Shiga toxin-producing Escherichia coli. Current Infectious Disease Reports 2:1.
Crossref
William H. Waugh, Charles L. Knupp & Darla K. Liles. (1999) Undetectable plasmaL-arginine level before visible hemolysis in thrombotic thrombocytopenic purpura. American Journal of Hematology 61:3, pages 216-216.
Crossref
Lillian R. Aronson & Clare Gregory. (2004) Possible Hemolytic Uremic Syndrome in Three Cats After Renal Transplantation and Cyclosporine Therapy. Veterinary Surgery 28:3, pages 135-140.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.